Rashmi Kshirsagar

Company: Be Biopharma

Job title: Senior Vice President

Seminars:

Approaches for Scalable Manufacturing of Engineered B-Cell Medicines: A New Class of Cellular Medicines 1:00 pm

Be Biopharma has developed a new class of cellular medicines – Engineered B-Cell Medicines (BCMs) – with the potential to be durable, allogeneic, redosable and administered without pre-conditioning B-Cell Medicines (BCMs) are produced with ex vivo precision engineering of B-cells using CRISPR/Cas9 and homology directed repair-mediated transgene insertion followed by ex vivo differentiation towards plasma cell lineage Process development, optimization and…Read more

day: Day Two - Track B PM